Startpage - Formycon AG

1-StartSlider_600x1920

Commercial Stage
Biosimilar Developer

As a globally operating, independent biosimilar developer, Formycon actively contributes to improving patients' access to high-quality, safe and affordable biologic medicines.

LEARN MORE

1-StartSlider_600x1920

At home in the
growth market of biosimilars

Through our biosimilar projects, we are not only developing high-quality medicines for patients but also creating sustainable value for investors.

ANNUAL REPORT 2024

1-StartSlider_600x1920

Our commitment to a
sustainable development

Our sustainability strategy describes how we intend to strengthen the positive impact of our business activities, minimize negative impacts and effectively mitigate sustainability-related risks.

LEARN MORE